[Hereditary colorectal cancer]

Med Clin (Barc). 2012 Mar 3;138(5):220-3. doi: 10.1016/j.medcli.2011.09.019. Epub 2011 Nov 16.
[Article in Spanish]

Abstract

Up to 5% of all diagnosed colorectal cancers has a hereditary cuase. Colon cancer arise in younger individuals, and extracolonic tumors are also frequent. A precise understanding of main syndromes will allow the proper management of these patients, including genetic counselling, screening and prophylactic surgery.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Adenomatous Polyposis Coli / diagnosis
  • Adenomatous Polyposis Coli / epidemiology
  • Adenomatous Polyposis Coli / genetics
  • Adenomatous Polyposis Coli / therapy
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Anticarcinogenic Agents / therapeutic use
  • Colectomy
  • Colonoscopy
  • Colorectal Neoplasms / diagnosis
  • Colorectal Neoplasms / epidemiology
  • Colorectal Neoplasms / genetics*
  • Colorectal Neoplasms / prevention & control
  • Colorectal Neoplasms / therapy
  • Colorectal Neoplasms, Hereditary Nonpolyposis / diagnosis
  • Colorectal Neoplasms, Hereditary Nonpolyposis / epidemiology
  • Colorectal Neoplasms, Hereditary Nonpolyposis / genetics
  • Colorectal Neoplasms, Hereditary Nonpolyposis / therapy
  • DNA Repair / genetics
  • Early Diagnosis
  • Female
  • Genes, APC
  • Genes, Neoplasm
  • Genetic Counseling
  • Genital Neoplasms, Female / epidemiology
  • Genital Neoplasms, Female / genetics
  • Humans
  • Male
  • Microsatellite Instability
  • Neoplasms, Multiple Primary
  • Neoplastic Syndromes, Hereditary* / diagnosis
  • Neoplastic Syndromes, Hereditary* / epidemiology
  • Neoplastic Syndromes, Hereditary* / genetics
  • Neoplastic Syndromes, Hereditary* / therapy

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Anticarcinogenic Agents